Cost-utility analysis of an implant treatment in dentistry

被引:4
|
作者
Losenicka, Johana [1 ]
Gajdos, Ondrej [1 ]
Kamensky, Vojtech [1 ]
机构
[1] Czech Tech Univ, Fac Biomed Engn, Dept Biomed Technol, Nam Sitna 3105, Kladno 27201, Czech Republic
关键词
Implant treatment; Implant; Fixed dental prosthesis; Cost-utility analysis; Markov models; FIXED PARTIAL DENTURES; DENTAL IMPLANTS; HEALTH; REPLACEMENT;
D O I
10.1186/s12903-021-01790-y
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background When dealing with the replacement of one missing tooth, the patient has the option of choosing between different types of treatment interventions. Several important factors play a role in his decision-making process, including his limited financial means and his efforts to solve the problem of missing teeth as effectively as possible. The main goal of the study is the economic-clinical evaluation of implant treatment, as a surgical-prosthetic method in dentistry, in case of replacement of one missing tooth of the molar area. Methods Cost-utility analysis from the patient's perspective is used for evaluation. The selected comparator is a purely prosthetic solution with the help of a three-unit fixed dental prosthesis. Cost-utility analysis is modelled using Markov models, which consider a 30-year time horizon. Results Based on the results of modelling, the intervention evaluated by the patient, i.e. treatment with the help of implant-supported single crown, brings exactly 15.31 quality-adjusted prosthesis years (QAPY) after 30 years. The value of incremental cost-utility ratio amounted to USD - 1434. Conclusion The results of the cost-utility analysis suggest that implant treatment with an implant-supported single crown is more cost-effective than treatment with the three-unit fixed dental prosthesis.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Rituximab for the treatment of pemphigus vulgaris in Australia: A cost-utility analysis
    Chen, Michelle
    Vissapragada, Ravi
    Bulamu, Norma
    Gupta, Monisha
    Sebaratnam, Deshan
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 : 13 - 13
  • [32] Cost-utility analysis of screening and laser treatment of retinopathy of prematurity
    Dunbar, Jennifer A.
    Hsu, Victoria
    Christensen, Marc
    Black, Bradley
    Williams, Pamela
    Beauchamp, George
    JOURNAL OF AAPOS, 2009, 13 (02): : 186 - 190
  • [33] COST-UTILITY ANALYSIS OF NIVOLUMAB MONOTHERAPY FOR METASTATIC MELANOMA TREATMENT
    Echave, M.
    Oyaguez, I
    Soria, A.
    de la Cruz-Merino, L.
    Arance, A.
    Carrasco, M.
    Gonzalez Garcia, P.
    VALUE IN HEALTH, 2016, 19 (07) : A739 - A739
  • [34] Cost-utility analysis of tegaserod for the treatment of irritable bowel syndrome
    Chen, SY
    Lin, PJ
    Biddle, AK
    VALUE IN HEALTH, 2006, 9 (03) : A46 - A47
  • [35] AGOMELATIN FOR TREATMENT OF DEPRESSIVE DISORDERS IN RUSSIA: A COST-UTILITY ANALYSIS
    Ignatyeva, V. I.
    Frolov, M. Y.
    Avksentyeva, M. V.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E102 - E102
  • [36] Treatment costs in Hodgkin's disease: A cost-utility analysis
    Norum, J
    Angelsen, V
    Wist, E
    Olsen, JA
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (09) : 1510 - 1517
  • [37] A COST-UTILITY ANALYSIS OF NIVOLUMAB IN THE ADJUVANT TREATMENT OF MELANOMA IN FRANCE
    Teitsson, S.
    Bregman, B.
    Cotte, F. E.
    Augusto, M.
    Amadi, A.
    Moshyk, A.
    Roze, S.
    Gaudin, A. F.
    VALUE IN HEALTH, 2019, 22 : S448 - S448
  • [38] A COST-UTILITY ANALYSIS OF DEGARELIX IN THE TREATMENT OF PROSTATE CANCER IN CHINA
    Yang, F.
    Du, X.
    Xuan, J.
    Fei, J.
    VALUE IN HEALTH, 2019, 22 : S35 - S36
  • [39] Cost-utility analysis of methadone maintenance treatment: A methodological approach
    Vanagas, G
    Padaiga, Z
    Bagdonas, E
    SUBSTANCE USE & MISUSE, 2006, 41 (01) : 87 - 101
  • [40] Cost-Utility Analysis of Nivolumab in Adjuvant Treatment of Melanoma in France
    Bregman, Bruno
    Teitsson, Siguroli
    Orsini, Isabella
    Cotte, Francois-Emery
    Amadi, Adenike
    Moshyk, Andriy
    Roze, Stephane
    Gaudin, Anne-Francoise
    DERMATOLOGY AND THERAPY, 2020, 10 (06) : 1331 - 1343